Mirvaso Gel (Brimonidine 0.33%)
Mirvaso is the new FDA approved treatment from Galderma that was previously known as Sansrosa, CD07805/47 and Col-118. Mirvaso is the only topical treatment officially approved for the relief of the red face of rosacea. Mirvaso is Brimonidine Topical Gel 0.33% and is available in 30g and 45g tubes, on prescription only. It is used once per day and can last as long as 12 hours.
See below for Mirvaso User Reviews, news and updates
Recent Rosacea Blog Posts
A patent application has emerged that suggests that Galderma might have their eye a future version of Mirvaso in a foam formulation. Read below for some clues as to why we shouldn’t be surprised to see Mirvaso Foam as a future product. NO-RINSE CHEMICAL FOAM CONTAINING BRIMONIDINE, AND USE THEREOF IN THE TREATMENT OF ROSACEA US […]
The regulator of healthcare products in the UK has issued a Drug Safety Update related to the topical treatment for the red face of rosacea – Mirvaso. This update was issued in June 2017 and seems to have gone largely unnoticed by rosacea sufferers online. Here is why it has been issued, and what […]
When faced with the prospect of paying $570 for a 30gm tube of Rhofade or $494 for a 30gm tube of Mirvaso, these authors suggest that you can save 15% straight up by asking to compare them before you even leave the doctor’s surgery. The 15% saving comes from going away being happy that […]
A clinical trial has been listed proposing the combination of Mirvaso and Dysport (the Galderma owned Botox-like product) to treat the redness and flushing of rosacea. So if you have ever wondered whether botox and Mirvaso might work well together, this trial is for you. The trial will examine how well the combination of Mirvaso […]
This paper from Drugs R&D, details an extensive treatment regimen undertaken to deal with a patient with a severe case of rosacea. Click the photo above for a larger view of their symptoms and how they improved over time. Note that only one side of their face was treated with Mirvaso in the hours before […]
